Mitochondrial dysfunction and possible treatments in Parkinson's disease - a review

被引:33
作者
Shults, CW
机构
[1] Univ Calif San Diego, Dept Neurosci, San Diego Sch Med, La Jolla, CA 92093 USA
[2] VA San Diego Healthcare Syst, Neurol Serv, San Diego, CA USA
关键词
mitochondria; Parkinson's disease; creatine;
D O I
10.1016/j.mito.2004.07.028
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitochondria are central not only to the bioenergetics of the cell but also to the process of apoptotic cell death. Substantial data indicate mitochondrial dysfunction, particularly of complex I of the electron transport chain, in some patients with Parkinson's disease (PD), and it appears likely that mitochondria contribute to the pathogenic processes that occurs in this disorder. Treatments targeted at mitochondrial function hold promise to slow the progression of PD. (C) 2004 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 61 条
[41]   Neuronal degeneration and mitochondrial dysfunction [J].
Schon, EA ;
Manfredi, G .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :303-312
[42]   Cyclosporin inhibition of apoptosis induced by mitochondrial complex I toxins [J].
Seaton, TA ;
Cooper, JM ;
Schapira, AHV .
BRAIN RESEARCH, 1998, 809 (01) :12-17
[43]   Mechanism of toxicity in rotenone models of Parkinson's disease [J].
Sherer, TB ;
Betarbet, R ;
Testa, CM ;
Seo, BB ;
Richardson, JR ;
Kim, JH ;
Miller, GW ;
Yagi, T ;
Matsuno-Yagi, A ;
Greenamyre, JT .
JOURNAL OF NEUROSCIENCE, 2003, 23 (34) :10756-10764
[44]   Effects of coenzyme Q10 in early Parkinson disease -: Evidence of slowing of the functional decline [J].
Shults, CW ;
Oakes, D ;
Kieburtz, K ;
Beal, MF ;
Haas, R ;
Plumb, S ;
Juncos, BL ;
Nutt, J ;
Shoulson, I ;
Carter, J ;
Kompoliti, K ;
Perlmutter, JS ;
Reich, S ;
Stern, M ;
Watts, RL ;
Kurlan, R ;
Molho, E ;
Harrison, M ;
Lew, M .
ARCHIVES OF NEUROLOGY, 2002, 59 (10) :1541-1550
[45]   CARBIDOPA-LEVODOPA AND SELEGILINE DO NOT AFFECT PLATELET MITOCHONDRIAL-FUNCTION IN EARLY PARKINSONISM [J].
SHULTS, CW ;
NASIRIAN, F ;
WARD, DM ;
NAKANO, K ;
PAY, M ;
HILL, LR ;
HAAS, RH .
NEUROLOGY, 1995, 45 (02) :344-348
[46]   Coenzyme Q(10) levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects [J].
Shults, CW ;
Haas, RH ;
Passov, D ;
Beal, MF .
ANNALS OF NEUROLOGY, 1997, 42 (02) :261-264
[47]   BIOCHEMICAL EVENTS IN THE DEVELOPMENT OF PARKINSONISM INDUCED BY 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
SINGER, TP ;
CASTAGNOLI, N ;
RAMSAY, RR ;
TREVOR, AJ .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (01) :1-8
[48]   α-synuclein locus triplication causes Parkinson's disease [J].
Singleton, AB ;
Farrer, M ;
Johnson, J ;
Singleton, A ;
Hague, S ;
Kachergus, J ;
Hulihan, M ;
Peuralinna, T ;
Dutra, A ;
Nussbaum, R ;
Lincoln, S ;
Crawley, A ;
Hanson, M ;
Maraganore, D ;
Adler, C ;
Cookson, MR ;
Muenter, M ;
Baptista, M ;
Miller, D ;
Blancato, J ;
Hardy, J ;
Gwinn-Hardy, K .
SCIENCE, 2003, 302 (5646) :841-841
[49]   Origin and functional consequences of the complex I defect in Parkinson's disease [J].
Swerdlow, RH ;
Parks, JK ;
Miller, SW ;
Tuttle, JB ;
Trimmer, PA ;
Sheehan, JP ;
Bennett, JP ;
Davis, RE ;
Parker, WD .
ANNALS OF NEUROLOGY, 1996, 40 (04) :663-671
[50]  
Tanner Caroline M., 2000, Current Opinion in Neurology, V13, P427, DOI 10.1097/00019052-200008000-00010